Skip to main content
. 2012 Jan 1;86(1):75–83. doi: 10.4269/ajtmh.2012.11-0192

Table 2.

Baseline characteristics of enrolled patients (safety population)*

Artemether-lumefantrineN = 159 Atovaquone-proguanilN = 53 Artesunate-mefloquineN = 53
Sex - n (%)
Male 96 (60.4) 34 (64.2) 31 (58.5)
Race - n (%)
Black 132 (83.0) 42 (79.2) 44 (83.0)
Hispanic 27 (17.0) 11 (20.8) 9 (17.0)
Mean Age (yr) 25.6 25.1 25.2
SD 11.6 11.2 11.3
Range 12–56 12–53 12–56
Age category - n (%)
< 18 years 51 (32.1) 21 (39.6) 18 (34.0)
18 to < 65 years 108 (67.9) 32 (60.4) 35 (66.0)
Mean weight (kg) 62.8 60.3 65.2
SD 14.4 14.5 15.4
Range 30.0–110.0 30.0–97.0 35.0–110.0
Weight category - n (%)
≥ 70 kg 50 (31.4) 18 (34.0) 19 (35.8)
BMI ≥ 25 kg/m2 50 (31.4) 11 (20.8) 21 (39.6)
Mean body temperature (°C) 37.8 37.7 37.8
SD 0.6 0.7 0.6
Range 36.5–40.0 36.5–40.0 36.0–40.0
Median parasite density, asexual forms (/μL) 3925 3864 4620
Range 1,008–44,744 1,030–31,124 1,012–35,112
*

BMI = body mass index; SD = standard deviation.